NCT07496645Not yet recruitingPhase 3
EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE
Source: ClinicalTrials.gov · Last updated 27 Mar 2026
Brief summary (registry, in English)
The use of transcranial direct current stimulation (tDCS) for the management of deficits developed in stroke is a relatively new type of management option. Many of the studies performed using tDCS have focused on improvements noted in hemiplegia as compared to aphasia, which is an equally disabling outcome of strokes. The results of these studies have not been conclusive and concordant with each other. In aphasia management, the majority of the studies have focused on chronic strokes. Since the use of tDCS is relatively new, the studies have not focused on a particular type of deficit or stroke. Very few studies have focused on the impact of solely using tDCS. Very few studies have focused on acute to subacute strokes. The results of the studies have, nevertheless, been encouraging. Improvements in aspects of language tested after a single session of tDCS are short-lived. There is an unmet need to probe the utility of repetitive tDCS on aspects of language function in patients who are aphasic due to acute stroke. There is also a paucity of data in the Indian scenario regarding the same.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- First submitted
- 21 Mar 2026
- Start date
- 31 Mar 2026
- Primary completion date
- 31 Aug 2026
- Lead sponsor
- Dr. Ram Manohar Lohia Hospital
- Diseases
- Stroke
- NCT number
- NCT07496645
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 28
- From 31 Mar 2026 to the primary completion date, 31 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with malignant Middle Cerebral Artery territory infarcts and previous clinical history of cerebral hemisphere stroke.
- Patients with history of previous brain surgery or skull defect due to surgery e.g. craniectomy.
- Patients with documented history of major depression prior to stroke.
- Patients with alcohol/drug abuse in the past 6 months.
- Patients with prior significant cognitive impairment.
- Pacemaker in situ, cochlear implant in situ.
Other illness
- Patients with epilepsy.
- Patients with history of significant head trauma in the last 1 month.
Other
- Pregnancy.
Who the study is looking for
- Aphasic patients with left middle cerebral artery territory Acute Ischemic Stroke
- Patients between 18-65 years of age.
- Within 5 days of onset of stroke.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi Coordinator of this site? Confirm its status | New Delhi | India | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.